https://www.mangaloremirror.com/dr-reddys-laboratories-enters-into-definitive-agreement-with-citius-pharmaceuticals-inc-to-sell-its-rights-to-anti-cancer-agent-e7777-denileukin-diftitox/
Dr. Reddy’s Laboratories enters into definitive agreement with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox)